MX2009011415A - Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion. - Google Patents
Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion.Info
- Publication number
- MX2009011415A MX2009011415A MX2009011415A MX2009011415A MX2009011415A MX 2009011415 A MX2009011415 A MX 2009011415A MX 2009011415 A MX2009011415 A MX 2009011415A MX 2009011415 A MX2009011415 A MX 2009011415A MX 2009011415 A MX2009011415 A MX 2009011415A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor antagonists
- alkoxypyridazine
- derivatives
- compounds
- fast dissociating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a (1-bencil-piperidin-4-il)-(4-al coxi-piridazin-3-il)-aminas de fórmula (I) (ver fórmula (I)) que son antagonistas del receptor de dopamina 2 de rápida disociación, procedimientos para preparar estos compuestos, composiciones farmacéuticas que comprenden estos compuestos como un ingrediente activo; los compuestos encuentran utilidad como medicamentos para tratar o prevenir trastornos del sistema nervioso central, por ejemplo esquizofrenia, al ejercer un efecto antipsicótico sin efectos secundarios motrices.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07106704 | 2007-04-23 | ||
PCT/EP2008/054731 WO2008128995A1 (en) | 2007-04-23 | 2008-04-18 | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011415A true MX2009011415A (es) | 2009-11-05 |
Family
ID=38476156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011415A MX2009011415A (es) | 2007-04-23 | 2008-04-18 | Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion. |
Country Status (19)
Country | Link |
---|---|
US (1) | US8906921B2 (es) |
EP (1) | EP2148873B1 (es) |
JP (1) | JP5431305B2 (es) |
KR (1) | KR20100016620A (es) |
CN (1) | CN101663292A (es) |
AU (1) | AU2008240728B2 (es) |
CA (1) | CA2683111A1 (es) |
CY (1) | CY1113820T1 (es) |
DK (1) | DK2148873T3 (es) |
ES (1) | ES2393818T3 (es) |
HR (1) | HRP20120913T1 (es) |
IL (1) | IL201663A (es) |
MX (1) | MX2009011415A (es) |
PL (1) | PL2148873T3 (es) |
PT (1) | PT2148873E (es) |
RS (1) | RS52518B (es) |
RU (1) | RU2464268C2 (es) |
SI (1) | SI2148873T1 (es) |
WO (1) | WO2008128995A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
EP2148872A1 (en) * | 2007-04-23 | 2010-02-03 | Janssen Pharmaceutica, N.V. | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
SI2148873T1 (sl) | 2007-04-23 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo |
WO2008128996A1 (en) * | 2007-04-23 | 2008-10-30 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
JP5417439B2 (ja) * | 2008-07-03 | 2014-02-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 5−ht6受容体アンタゴニストとしての置換された6−(1−ピペラジニル)−ピリダジン類 |
CA2730774C (en) | 2008-07-31 | 2016-09-13 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
US8324239B2 (en) | 2010-04-21 | 2012-12-04 | Novartis Ag | Furopyridine compounds and uses thereof |
EP3016949B1 (en) | 2013-07-02 | 2020-05-13 | Syngenta Participations AG | Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3933823A (en) * | 1971-03-29 | 1976-01-20 | E. R. Squibb & Sons, Inc. | Isoxazolopyridine ketone derivatives |
DE2341965C3 (de) * | 1973-08-20 | 1979-01-25 | C.H. Boehringer Sohn, 6507 Ingelheim | 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen |
NO147672C (no) | 1975-09-23 | 1983-05-25 | Janssen Pharmaceutica Nv | Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider |
US4197304A (en) * | 1975-09-23 | 1980-04-08 | Janssen Pharmaceutica N.V. | N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides |
EG12406A (en) * | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
DE3218482A1 (de) * | 1982-05-15 | 1983-11-17 | Bayer Ag, 5090 Leverkusen | Substituierte 5-trifluormethyl-1,3,4-thiadiazol-2-yloxyessigsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
ES8802151A1 (es) | 1985-07-31 | 1988-04-01 | Janssen Pharmaceutica Nv | Un procedimiento para la preparacion de nuevos piridazinaminas. |
MX173362B (es) | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
GB9216298D0 (en) | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
CA2176722A1 (en) | 1993-12-28 | 1995-07-06 | Ruth E. Ten Brink | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
DE4425145A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung von Thiazol- und Thiadiazolverbindungen |
TW406075B (en) | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
US5560931A (en) * | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5753679A (en) | 1995-05-10 | 1998-05-19 | Hoffmann-La Roche Inc. | Benzyl-piperidine derivatives |
MY116093A (en) * | 1996-02-26 | 2003-11-28 | Upjohn Co | Azolyl piperazinyl phenyl oxazolidinone antimicrobials |
TW504510B (en) | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
IL133960A0 (en) | 1997-08-15 | 2001-04-30 | Pfizer Prod Inc | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives |
KR100261139B1 (ko) | 1998-01-16 | 2000-08-01 | 황준수 | 신규한 알릴티오피리다진 유도체 및 그의 제조방법 |
AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
NZ527365A (en) * | 2001-02-23 | 2005-08-26 | Merck & Co Inc | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
KR100938369B1 (ko) | 2001-10-09 | 2010-01-22 | 교린 세이야꾸 가부시키 가이샤 | 신규 4-(2-푸로일)아미노피페리딘, 그의 합성 중간체,그의 제조방법 및 의약으로서의 그의 용도 |
GB0127832D0 (en) | 2001-11-20 | 2002-01-09 | Jagotec Ag | Method for the preparation of pharmaceutical nanosuspensions |
AU2002360561A1 (en) | 2001-12-11 | 2003-06-23 | Sepracor, Inc. | 4-substituted piperidines, and methods of use thereof |
CA2474322A1 (en) | 2002-01-25 | 2003-07-31 | Kylix Pharmaceuticals B.V. | 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
IL162859A0 (en) | 2002-02-05 | 2005-11-20 | Novo Nordisk As | Novel aryl-and heteroarylpiperazines |
MXPA04008097A (es) | 2002-02-22 | 2004-11-26 | Upjohn Co | Derivados de piridilsulfona como antagonistas del receptor 5-ht. |
SE0201544D0 (sv) | 2002-05-17 | 2002-05-17 | Biovitrum Ab | Novel compounds and thier use |
EP1543830B1 (en) * | 2002-09-26 | 2012-03-28 | Mandom Corporation | Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
AU2004224191A1 (en) | 2003-03-24 | 2004-10-07 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
ATE476954T1 (de) | 2003-05-07 | 2010-08-15 | Kemira Pigments Oy | Zusammensetzungen zur gezielten freisetzung von duftstoffen und aromen |
CA2524498C (en) | 2003-05-08 | 2012-01-24 | Kyorin Pharmaceutical Co., Ltd. | 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
WO2005005779A2 (en) | 2003-07-14 | 2005-01-20 | Genesis Mining Technologies (Pty) Ltd | Dual retention cutting arrangement |
ES2342605T3 (es) | 2003-07-29 | 2010-07-09 | High Point Pharmaceuticals, Llc | Piridazinil-piperazinas y su uso como ligandos del receptor histaminico h3. |
EP3042895A1 (en) | 2003-07-30 | 2016-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
JP2007501801A (ja) | 2003-08-07 | 2007-02-01 | 日本たばこ産業株式会社 | ピロロ[1,2−b]ピリダジン誘導体 |
WO2005046581A2 (en) | 2003-10-24 | 2005-05-26 | Cheng Tao M D | P18 in stem cell manipulations |
MXPA06009099A (es) | 2004-02-10 | 2007-02-02 | Johnson & Johnson | Piridazinona ureas como antagonistas de las integrinas alfa-4. |
EP1730120A1 (en) | 2004-03-23 | 2006-12-13 | F.Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
WO2005105779A1 (en) | 2004-04-28 | 2005-11-10 | Pfizer Limited | 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
EP1753429A1 (en) | 2004-05-28 | 2007-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
BRPI0515505A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase |
AU2005286731A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
AR052319A1 (es) | 2004-10-29 | 2007-03-14 | Kalypsys Inc | Compuestos biciclicos sustituidos por sulfonilo en funcion de moduladores del ppar |
AU2005313391A1 (en) * | 2004-12-08 | 2006-06-15 | Solvay Pharmaceuticals B.V. | Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
CA2602654A1 (en) * | 2005-04-05 | 2006-10-12 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Method for shielding functional sites or epitopes on proteins |
MX2008000115A (es) | 2005-06-20 | 2008-03-18 | Schering Corp | Derivados de piperidina utiles como antagonistas de histamina h3. |
JO2769B1 (en) * | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
WO2007130383A2 (en) | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
US8058243B2 (en) * | 2006-10-13 | 2011-11-15 | Hsc Research And Development Limited Partnership | Method for treating a brain cancer with ifenprodil |
JO2642B1 (en) * | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
TW200829566A (en) | 2006-12-08 | 2008-07-16 | Astrazeneca Ab | Chemical compounds |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
SI2148873T1 (sl) | 2007-04-23 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo |
WO2008128996A1 (en) * | 2007-04-23 | 2008-10-30 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
EP2148872A1 (en) * | 2007-04-23 | 2010-02-03 | Janssen Pharmaceutica, N.V. | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
PE20091194A1 (es) * | 2007-09-20 | 2009-09-05 | Glaxo Group Ltd | Derivados de heterociclicos como moduladores del receptor m1 |
JP5417439B2 (ja) * | 2008-07-03 | 2014-02-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 5−ht6受容体アンタゴニストとしての置換された6−(1−ピペラジニル)−ピリダジン類 |
CA2730774C (en) | 2008-07-31 | 2016-09-13 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
-
2008
- 2008-04-18 SI SI200830823T patent/SI2148873T1/sl unknown
- 2008-04-18 PT PT08749604T patent/PT2148873E/pt unknown
- 2008-04-18 CN CN200880012952A patent/CN101663292A/zh active Pending
- 2008-04-18 AU AU2008240728A patent/AU2008240728B2/en not_active Ceased
- 2008-04-18 ES ES08749604T patent/ES2393818T3/es active Active
- 2008-04-18 PL PL08749604T patent/PL2148873T3/pl unknown
- 2008-04-18 DK DK08749604.8T patent/DK2148873T3/da active
- 2008-04-18 KR KR1020097023941A patent/KR20100016620A/ko not_active Application Discontinuation
- 2008-04-18 CA CA002683111A patent/CA2683111A1/en not_active Abandoned
- 2008-04-18 RS RS20120481A patent/RS52518B/en unknown
- 2008-04-18 MX MX2009011415A patent/MX2009011415A/es active IP Right Grant
- 2008-04-18 WO PCT/EP2008/054731 patent/WO2008128995A1/en active Application Filing
- 2008-04-18 EP EP08749604A patent/EP2148873B1/en active Active
- 2008-04-18 US US12/597,166 patent/US8906921B2/en active Active
- 2008-04-18 RU RU2009142997/04A patent/RU2464268C2/ru active
- 2008-04-18 JP JP2010504647A patent/JP5431305B2/ja active Active
-
2009
- 2009-10-21 IL IL201663A patent/IL201663A/en active IP Right Grant
-
2012
- 2012-11-13 HR HRP20120913AT patent/HRP20120913T1/hr unknown
- 2012-11-28 CY CY20121101154T patent/CY1113820T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20100063058A1 (en) | 2010-03-11 |
JP2010525014A (ja) | 2010-07-22 |
PL2148873T3 (pl) | 2013-01-31 |
WO2008128995A1 (en) | 2008-10-30 |
RU2464268C2 (ru) | 2012-10-20 |
HRP20120913T1 (hr) | 2012-12-31 |
CA2683111A1 (en) | 2008-10-30 |
RS52518B (en) | 2013-04-30 |
EP2148873A1 (en) | 2010-02-03 |
EP2148873B1 (en) | 2012-08-29 |
DK2148873T3 (da) | 2012-11-26 |
AU2008240728B2 (en) | 2013-01-10 |
US8906921B2 (en) | 2014-12-09 |
IL201663A0 (en) | 2010-05-31 |
RU2009142997A (ru) | 2011-05-27 |
ES2393818T3 (es) | 2012-12-28 |
KR20100016620A (ko) | 2010-02-12 |
CY1113820T1 (el) | 2016-10-05 |
IL201663A (en) | 2013-05-30 |
PT2148873E (pt) | 2012-11-20 |
AU2008240728A1 (en) | 2008-10-30 |
JP5431305B2 (ja) | 2014-03-05 |
SI2148873T1 (sl) | 2013-01-31 |
CN101663292A (zh) | 2010-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1124317A1 (en) | Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists | |
JO2849B1 (en) | Dopamine 2 receptor antagonists are rapidly hydrolyzed | |
MX2009011415A (es) | Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion. | |
TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
PH12015502524A1 (en) | New somatostatin receptor subtype 4 (sstr4) agonists | |
MX2009005252A (es) | Aminopirrolidinas como antagonistas del receptor de quimiocina. | |
TW200719886A (en) | Dihydrobenzofuran derivatives and uses thereof | |
WO2008132139A3 (en) | New heterocyclic derivatives useful for the treatment of cns disorders | |
TW200700391A (en) | Pyridine-2-carboxamide derivatives as mglur5 antagonists | |
MX2007011847A (es) | Derivados de pirimidindiona como antagonistas del receptor de procineticina 2. | |
MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
MX2010001486A (es) | Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl. | |
MY148772A (en) | Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists | |
EA201170256A1 (ru) | Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d2 рецепторов дофамина | |
GB0513886D0 (en) | Novel compounds | |
MX2009011414A (es) | Derivados de piridina como antagonistas del receptor de dopamina 2 de disociacion rapida. | |
MX2009011416A (es) | Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida. | |
WO2009076408A3 (en) | 3 -carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists | |
WO2008063548A3 (en) | 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents | |
TH98889B (th) | แอนตาโกนิสต์สำหรับโดปามีน 2 รีเซบเตอร์ที่แยกตัวเร็ว | |
UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов | |
TH88506B (th) | แอนทาโกนิสท์ตัวรับโดพามีน 2 ที่มีการแตกตัวอย่างรวดเร็ว | |
TH98889A (th) | แอนตาโกนิสต์สำหรับโดปามีน 2 รีเซบเตอร์ที่แยกตัวเร็ว | |
NI200800105A (es) | Antagonistas de los receptores 2 de dopamina de rapida disociación |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |